Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictors of Success of High Flow Nasal Therapy in Covid 19 Patients

NCT05094648 is registered in ClinicalTrials.gov with Maha Mahmoud Ahmed as lead sponsor.

NCT NCT05094648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05094648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictors of Success of High Flow Nasal Therapy in Covid 19 Patients
Lead sponsor
Maha Mahmoud Ahmed
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2021
Completion date
September 30, 2022
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

high flow nasal therapy